Hospital
Down East Community Hospital
Down East Community Hospital was paid $4.46M by Medicaid between Jan 2018 and Dec 2024, across 256 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 15% of everything it billed.
33Billing provider infoDOWN EAST COMMUNITY HOSPITAL
MACHIAS, ME 04654
MACHIAS, ME 04654
33aNPI1528087004assigned 07/18/2006
33bProvider typeCritical Access Hospital
28Total paid$4.46M
24GClaims522,051
24DCodes billed256
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Maine
Rank by total paid#1 of 14
Median peer was paid$1.76M
This provider vs. median2.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 71,092 | $616K | |
| 2019 | 72,964 | $574K | |
| 2020 | 75,118 | $714K | |
| 2021 | 79,995 | $739K | |
| 2022 | 74,748 | $615K | |
| 2023 | 77,418 | $590K | |
| 2024incomplete | 70,716 | $615K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 31,908 | 26,542 | $674K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 52,184 | 41,352 | $601K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 7.5% | 4,200 | 1,994 | $335K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.6% | 10,322 | 6,777 | $249K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.1% | 18,088 | 11,518 | $225K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.5% | 4,054 | 1,919 | $200K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.3% | 2,804 | 2,311 | $147K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.0% | 21,181 | 12,391 | $135K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.5% | 6,448 | 5,568 | $112K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.2% | 1,841 | 1,774 | $98K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.9% | 3,943 | 3,410 | $85K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.9% | 11,560 | 3,832 | $83K |
244 more codes
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.8% | 453 | $79K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.7% | 7,612 | $76K |
| 71046 | Radiologic examination, chest; 2 views | 1.7% | 6,375 | $74K |
| 71045 | Radiologic examination, chest; single view | 1.7% | 6,899 | $74K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.5% | 11,396 | $67K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.4% | 2,036 | $64K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.4% | 3,766 | $62K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.4% | 5,127 | $61K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.3% | 1,098 | $60K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.3% | 809 | $58K |
| 99203 | Doctor's office visit, new patient (routine) | 1.0% | 3,638 | $45K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 15,675 | $44K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,857 | $42K |
| 45384 | <1% | 596 | $42K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,777 | $36K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 2,231 | $32K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,810 | $28K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 557 | $27K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,085 | $27K |
| 73030 | <1% | 1,905 | $26K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,785 | $21K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 371 | $19K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 414 | $19K |
| 59025 | Fetal non-stress test | <1% | 3,007 | $18K |
| 96376 | <1% | 947 | $17K | |
| 80053 | Comprehensive metabolic panel | <1% | 26,267 | $16K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 345 | $15K |
| 73564 | <1% | 682 | $14K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 3,416 | $14K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 24,082 | $12K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,578 | $10K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 132 | $10K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,983 | $10K |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 1,578 | $9K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 225 | $8K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 587 | $8K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,813 | $8K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 553 | $8K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,388 | $7K |
| 20610 | <1% | 516 | $7K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,438 | $7K |
| 99406 | <1% | 884 | $7K | |
| 97161 | <1% | 873 | $6K | |
| 80305 | <1% | 694 | $6K | |
| 73630 | <1% | 717 | $5K | |
| 82728 | <1% | 3,929 | $5K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 520 | $5K |
| 72275 | <1% | 312 | $5K | |
| 99000 | <1% | 1,441 | $5K | |
| 90686 | <1% | 994 | $5K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 532 | $4K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 592 | $4K |
| 90837 | Psychotherapy session, about an hour | <1% | 85 | $4K |
| 84484 | <1% | 4,017 | $4K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 59 | $4K |
| 90474 | <1% | 877 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,215 | $4K |
| D1206 | Topical application of fluoride varnish | <1% | 357 | $4K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 5,191 | $4K |
| J3490 | Unclassified drugs | <1% | 6,307 | $4K |
| 73110 | <1% | 464 | $4K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 882 | $4K |
| 76775 | <1% | 241 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,084 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,902 | $4K |
| 85027 | <1% | 4,376 | $3K | |
| 82607 | <1% | 2,965 | $3K | |
| 97162 | <1% | 388 | $3K | |
| 73502 | <1% | 449 | $3K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 2,069 | $3K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 191 | $3K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 69 | $3K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,354 | $3K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 4,183 | $3K |
| 76642 | <1% | 204 | $3K | |
| 71250 | <1% | 25 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,993 | $3K |
| 83880 | <1% | 1,573 | $3K | |
| 81025 | <1% | 3,118 | $3K | |
| J2704 | Injection, propofol, 10 mg | <1% | 331 | $3K |
| 83605 | <1% | 2,089 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,106 | $3K |
| 73610 | <1% | 612 | $2K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 77 | $2K |
| 90715 | <1% | 52 | $2K | |
| 76536 | <1% | 98 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,236 | $2K |
| 90473 | <1% | 525 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 247 | $2K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 5,680 | $2K |
| 99460 | <1% | 37 | $2K | |
| 73562 | <1% | 181 | $2K | |
| 82803 | <1% | 740 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 190 | $2K |
| 87040 | <1% | 927 | $2K | |
| 83735 | <1% | 8,248 | $2K | |
| 36592 | <1% | 461 | $2K | |
| 84145 | <1% | 505 | $2K | |
| 76830 | Ultrasound, transvaginal | <1% | 189 | $2K |
| 83540 | <1% | 3,820 | $1K | |
| 83690 | <1% | 3,225 | $1K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,325 | $1K |
| 36416 | <1% | 658 | $1K | |
| 80306 | <1% | 3,893 | $1K | |
| 90670 | <1% | 1,345 | $1K | |
| 81001 | <1% | 5,300 | $1K | |
| 85018 | <1% | 502 | $1K | |
| 73130 | <1% | 179 | $1K | |
| 94760 | <1% | 548 | $1K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 447 | $1K |
| 85610 | <1% | 3,324 | $1K | |
| 95806 | <1% | 157 | $1K | |
| 84439 | <1% | 1,558 | $1K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 27 | $1K |
| 80061 | Lipid panel | <1% | 8,676 | $1K |
| 76857 | <1% | 79 | $948.78 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 392 | $942.23 |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 33 | $924.46 |
| 83550 | <1% | 3,585 | $921.05 | |
| 85652 | <1% | 1,774 | $918.64 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 716 | $861.06 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,339 | $854.99 |
| 87077 | <1% | 2,350 | $846.61 | |
| 62323 | <1% | 26 | $813.28 | |
| 00812 | <1% | 176 | $795.72 | |
| 87186 | <1% | 1,411 | $750.80 | |
| 96367 | <1% | 93 | $677.91 | |
| 84153 | <1% | 462 | $675.34 | |
| 82043 | <1% | 703 | $669.22 | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 283 | $649.60 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 84 | $640.67 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 211 | $637.95 |
| A4221 | Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately) | <1% | 317 | $637.69 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 332 | $625.14 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 341 | $570.90 |
| 86140 | <1% | 2,041 | $557.80 | |
| 81003 | <1% | 3,895 | $537.66 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 49 | $489.12 |
| 93971 | <1% | 24 | $471.53 | |
| 85730 | <1% | 766 | $423.22 | |
| 96523 | <1% | 40 | $420.93 | |
| 86850 | <1% | 1,073 | $412.08 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 229 | $411.97 |
| 51702 | <1% | 26 | $410.33 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 41 | $399.41 |
| 86900 | <1% | 1,140 | $385.73 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 42 | $348.66 |
| 72100 | <1% | 28 | $321.07 | |
| 99462 | <1% | 15 | $318.50 | |
| 85378 | <1% | 583 | $295.36 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 12 | $274.34 |
| 94060 | <1% | 30 | $272.49 | |
| 90662 | <1% | 117 | $265.06 | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 64 | $263.21 |
| 87070 | <1% | 948 | $262.04 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 498 | $243.61 |
| 86803 | <1% | 829 | $226.59 | |
| 69210 | <1% | 25 | $218.28 | |
| 83921 | <1% | 447 | $215.44 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 233 | $195.08 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,204 | $190.39 |
| 82746 | <1% | 218 | $180.61 | |
| 90710 | <1% | 27 | $162.26 | |
| 80320 | <1% | 203 | $159.75 | |
| 00731 | <1% | 13 | $158.48 | |
| 87807 | <1% | 12 | $140.52 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 839 | $138.85 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 67 | $128.58 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,294 | $124.26 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 30 | $120.63 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 45 | $119.86 |
| 81002 | <1% | 140 | $114.88 | |
| 00813 | <1% | 12 | $114.59 | |
| 99442 | <1% | 20 | $109.20 | |
| 86618 | <1% | 181 | $107.44 | |
| 76000 | <1% | 22 | $89.65 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,825 | $88.20 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 193 | $79.32 |
| 86901 | <1% | 218 | $74.20 | |
| 86038 | <1% | 13 | $72.82 | |
| 87205 | <1% | 920 | $70.54 | |
| 11721 | <1% | 15 | $60.27 | |
| 71271 | <1% | 25 | $59.50 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 89 | $51.43 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 15 | $48.20 |
| 82550 | <1% | 161 | $47.14 | |
| 86431 | <1% | 26 | $45.84 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 2,085 | $42.82 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 58 | $41.34 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 120 | $38.35 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 75 | $32.69 |
| 82565 | <1% | 17 | $32.24 | |
| Q2039 | Influenza virus vaccine, not otherwise specified | <1% | 198 | $31.12 |
| 84520 | <1% | 14 | $29.72 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 18 | $24.26 |
| 99201 | <1% | 33 | $22.68 | |
| G0008 | Administration of influenza virus vaccine | <1% | 327 | $15.89 |
| 82140 | <1% | 20 | $15.26 | |
| 84100 | <1% | 96 | $14.76 | |
| 80329 | <1% | 15 | $12.60 | |
| 83655 | <1% | 802 | $12.37 | |
| 84702 | <1% | 327 | $11.21 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 336 | $9.41 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 109 | $6.69 |
| 85007 | <1% | 105 | $5.15 | |
| 90680 | <1% | 968 | $4.45 | |
| 90648 | <1% | 828 | $3.14 | |
| 90660 | <1% | 534 | $2.79 | |
| 90633 | <1% | 494 | $2.22 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 31 | $2.20 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 607 | $1.71 |
| 90723 | <1% | 435 | $1.61 | |
| 90716 | <1% | 54 | $0.35 | |
| 90656 | <1% | 28 | $0.27 | |
| 90700 | <1% | 54 | $0.24 | |
| 90698 | <1% | 49 | $0.22 | |
| 90696 | <1% | 43 | $0.20 | |
| 90734 | <1% | 43 | $0.20 | |
| 90707 | <1% | 32 | $0.19 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 0% | 87 | $0.00 |
| 90697 | 0% | 106 | $0.00 | |
| 87081 | 0% | 330 | $0.00 | |
| 86762 | 0% | 117 | $0.00 | |
| 87467 | 0% | 45 | $0.00 | |
| 86592 | 0% | 226 | $0.00 | |
| 82950 | 0% | 52 | $0.00 | |
| 87340 | 0% | 168 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 116 | $0.00 |
| 80055 | 0% | 34 | $0.00 | |
| 90694 | 0% | 31 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 21 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 16 | $0.00 |
| 99205 | Prolong outpt/office vis | 0% | 13 | $0.00 |
| 92567 | 0% | 13 | $0.00 | |
| 87631 | 0% | 222 | $0.00 | |
| 86703 | 0% | 424 | $0.00 | |
| 90649 | 0% | 115 | $0.00 | |
| 84466 | 0% | 60 | $0.00 | |
| 77003 | 0% | 41 | $0.00 | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 0% | 15 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 25 | $0.00 |
| 84550 | 0% | 55 | $0.00 | |
| 84403 | 0% | 27 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBROWN, VICKI (PFS DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Down East Community Hospital | Jonesport, ME | $2.09M |
| Down East Community Hospital | Milbridge, ME | $1.81M |
| Down East Community Hospital | Machias, ME | $67K |
| Down East Community Hospital | Calais, ME | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.